We investigated the potential of melatonin as a PDE4 inhibitor in the treatment of COPD by exposing mice to CS and stimulating airway epithelial cells by cigarette smoke condensate (CSC). This evidence concerns the gene PDE4A and chronic obstructive pulmonary disease.